Overview

An important novel menu for Survival Analysis entitled Accelerated Failure Time (AFT) models has been published by IBM (international Businesss Machines) in its SPSS statistical software update of 2023. Unlike the traditional Cox regressions that work with hazards, which are the ratio of deaths and non-deaths in a sample, it works with risk of death, which is the proportion of deaths in the same sample. The latter approach may provide better sensitivity of testing, but has been seldom applied, because with computers risks are tricky and hazards because they are odds are fine. This was underscored in 1997 by Keiding and colleague statisticians from Copenhagen University who showed better-sensitive goodness of fit and null-hypothesis tests with AFT than with Cox survival tests. So far, a controlled study of a representative sample of clinical Kaplan Meier assessments, where the sensitivity of Cox regression is systematically tested against that of AFT modeling, hasnot been accomplished. This edition is the first textbook and tutorial of AFT modeling both for medical and healthcare students and for professionals. Each chapter can be studied as a standalone, and, using, real as well as hypothesized data, it tests the performance of the novel methodology against traditional Cox regressions. Step by step analyses of over 20 data files stored at Supplementary Files at Springer Interlink are included for self-assessment. We should add that the authors are well qualified in their field. Professor Zwinderman is past-president of the International Society of Biostatistics (2012-2015) and Professor Cleophas is past-president of the American College of Angiology (2000-2002). From their expertise they should be able to make adequate selections of modern data analysis methods for the benefit of physicians, students, and investigators. The authors have been working and publishing together for 25 years and their research can be characterized asa continued effort to demonstrate that clinical data analysis is not mathematics but rather a discipline at the interface of biology and mathematics.

Full Product Details

Author:   Ton J. Cleophas ,  Aeilko H. Zwinderman
Publisher:   Springer International Publishing AG
Imprint:   Springer International Publishing AG
Edition:   1st ed. 2023
Weight:   0.573kg
ISBN:  

9783031316319

ISBN 10:   3031316312
Pages:   224
Publication Date:   30 May 2023
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

PrefaceChapter 1: Regression Analysis 1.1 Introduction 1.2 History 1.3 Methodology of Regression Analysis 1.3.1 Linear Regression 1.3.2 Logistic Regression 1.3.3 Cox Regression 1.4 Conclusion 1.5 References Chapter 2: Cox Regressions 2.1 Introduction 2.2 History of Cox Regressions 2.3 Principles of Cox Regressions 2.4 Conclusion 2.5 References Chapter 3: Accelerated Failure Time Models 3.1 Introduction 3.2 History of Failure Time Models 3.3 Methodologies of Failure Time Models 3.4 Graphs of Successfyk Functions to Analyze Accelerated Failure Time Models 3.5 Conclusion 3.6 References Chapter 4: Simple Dataset with Event as Outcome and Treatment as Predictor 4.1 Introduction 4.2 Data Example 4.3 Data Analysis Using SPSS Statistical Software Version 29 4.4 Cox Regression 4.5 Accelerated Failure Time Model with Weibull Distribution 4.6 Accelerated Failure Time Model with Exponential Distribution 4.7 Accelerated Failure Time Model with Log Normal Distribution 4.8 Accelerated Failure Time Model with Log Logistics Distribution 4.9 Conclusion 4.10 References Chapter 5: Simple Dataset with Death as Outcome and Treatment Modality, Cholesterol, and Age as Predictors 5.1 Introduction 5.2 Data Example 5.3 Data Analysis Using SPSS Statistical Software Version 29 5.4 Three Predictors Cox Regression 5.5 Accelerated Failure Time Model with Weibull Distribution 5.6 Accelerated Failure Time Model with Exponential Distribution 5.7 Accelerated Failure Time Model with Log Normal Distribution 5.8 Accelerated Failure Time Model with Log Logistics Distribution 5.9 Conclusion 5.10 References Chapter 6: Glioma Brain Cancer 6.1 Introduction 6.2 Data Example 6.3 Data Analysis Using SPSS Statistical Software Version 29 6.4 Cox Regression 6.5 Accelerated Failure Time Model with Weibull Distribution 6.6 Accelerated Failure Time Model with Exponential Distribution 6.7 Accelerated Failure Time Model with Log Normal Distribution 6.8 Accelerated Failure Time Model with Log Logistics Distribution 6.9 Conclusion 6.10 References Chapter 7: Linoleic Acid for Colonic Carcinoma 7.1 Introduction 7.2 Data Example 7.3 Data Analysis Using SPSS Statistical Software Version 29 7.4 Cox Regression 7.5 Accelerated Failure Time Model with Weibull Distribution 7.6 Accelerated Failure Time Model with Exponential Distribution 7.7 Accelerated Failure Time Model with Log Normal Distribution 7.8 Accelerated Failure Time Model with Log Logistics Distribution 7.9 Conclusion 7.10 References Chapter 8: The Effect on Survival of Maintained Chemotherapy with Acute Myelogenous Leucemia 8.1 Introduction 8.2 Data Example 8.3 Data Analysis Using SPSS Statistical Software Version 29 8.4 Cox Regression 8.5 Accelerated Failure Time Model with Weibull Distribution 8.6 Accelerated Failure Time Model with Exponential Distribution 8.7 Accelerated Failure Time Model with Log Normal Distribution 8.8 Accelerated Failure Time Model with Log Logistics Distribution 8.9 Conclusion 8.10 References Chapter 9: Eighty Four Month Parallel Group Mortality Study 9.1 Introduction 9.2 Data Example 9.3 Data Analysis Using SPSS Statistical Software Version 29 9.4 Cox Regression 9.5 Accelerated Failure Time Model with Weibull Distribution 9.6 Accelerated Failure Time Model with Exponential Distribution 9.7 Accelerated Failure Time Model with Log Normal Distribution 9.8 Accelerated Failure Time Model with Log Logistics Distribution 9.9 Conclusion 9.10 References Chapter 10: The Effect on Survival from Stages 1 and 2 Histiocytic Lymphoma 10.1 Introduction 10.2 Data Example 10.3 Data Analysis Using SPSS Statistical Software Version 29 10.4 Cox Regression 10.5 Accelerated Failure Time Model with Weibull Distribution 10.6 Accelerated Failure Time Model with Exponential Distribution 10.7 Accelerated Failure Time Model with Log Normal Distribution 10.8 Accelerated Failure Time Model with Log Logistics Distribution 10.9 Conclusion 10.10 References Chapter 11: Survival of 64 Lymphoma Patients with or without B Symptoms 11.1 Introduction 11.2 Data Example 11.3 Data Analysis Using SPSS Statistical Software Version 29 11.4 Cox Regression 11.5 Accelerated Failure Time Model with Weibull Distribution 11.6 Accelerated Failure Time Model with Exponential Distribution 11.7 Accelerated Failure Time Model with Log Normal Distribution 11.8 Accelerated Failure Time Model with Log Logistics Distribution 11.9 Conclusion 11.10 References Chapter 12: Effect on Time-to-Event of Group Membership 12.1 Introduction 12.2 Data Example 12.3 Data Analysis Using SPSS Statistical Software Version 29 12.4 Cox Regression 12.5 Accelerated Failure Time Model with Weibull Distribution 12.6 Accelerated Failure Time Model with Exponential Distribution 12.7 Accelerated Failure Time Model with Log Normal Distribution 12.8 Accelerated Failure Time Model with Log Logistics Distribution 12.9 Conclusion 12.10 References Chapter 13: The Effect on Survival of Group Membership 13.1 Introduction 13.2 Data Example 13.3 Data Analysis Using SPSS Statistical Software Version 29 13.4 Cox Regression 13.5 Accelerated Failure Time Model with Weibull Distribution 13.6 Accelerated Failure Time Model with Exponential Distribution 13.7 Accelerated Failure Time Model with Log Normal Distribution 13.8 Accelerated Failure Time Model with Log Logistics Distribution 13.9 Conclusion 13.10 References Chapter 14: Deaths from Carcinoma after Exposure to Carcinogens in Rats 14.1 Introduction 14.2 Data Example 14.3 Data Analysis Using SPSS Statistical Software Version 29 14.4 Cox Regression 14.5 Accelerated Failure Time Model with Weibull Distribution 14.6 Accelerated Failure Time Model with Exponential Distribution 14.7 Accelerated Failure Time Model with Log Normal Distribution 14.8 Accelerated Failure Time Model with Log Logistics Distribution 14.9 Conclusion 14.10 References Chapter 15: Effect of Group Membership on Survival 15.1 Introduction 15.2 Data Example 15.3 Data Analysis Using SPSS Statistical Software Version 29 15.4 Cox Regression 15.5 Accelerated Failure Time Model with Weibull Distribution 15.6 Accelerated Failure Time Model with Exponential Distribution 15.7 Accelerated Failure Time Model with Log Normal Distribution 15.8 Accelerated Failure Time Model with Log Logistics Distribution 15.9 Conclusion 15.10 References Chapter 16: Multiple Variables Regression Study of 2421 Stroke Patients Assessed for Time to Second Stroke 16.1 Introduction and Sata Example 16.2 Data Analysis Using SPSS Statistical Software Version 29 16.3 Cox Regression 16.4 Accelerated Failure Time Model with Weibull Distribution 16.5 Accelerated Failure Time Model with Exponential Distribution 16.6 Accelerated Failure Time Model with Log Normal Distribution 16.7 Accelerated Failure Time Model with Log Logistics Distribution 16.8 Conclusion 16.9 References Chapter 17: Hypothesized 55 Patient Study of Effect of Treatment Modality on Survival 17.1 Introduction 17.2 Data Example 17.3 Data Analysis Using SPSS Statistical Software Version 29 17.4 Cox Regression 17.5 Accelerated Failure Time Model with Weibull Distribution 17.6 Accelerated Failure Time Model with Exponential Distribution 17.7 Accelerated Failure Time Model with Log Normal Distribution 17.8 Accelerated Failure Time Model with Log Logistics Distribution 17.9 Conclusion 17.10 References Chapter 18: One Year Follow-up Study with Many Censored Patients 18.1 Introduction 18.2 Data Example 18.3 Data Analysis Using SPSS Statistical Software Version 29 18.4 Cox Regression 18.5 Accelerated Failure Time Model with Weibull Distribution 18.6 Accelerated Failure Time Model with Exponential Distribution 18.7 Accelerated Failure Time Model with Log Normal Distribution 18.8 Accelerated Failure Time Model with Log Logistics Distribution 18.9 Conclusion 18.10 References Chapter 19: Alcohol Relapse after Detox Program Treated with or without Personal Coach 19.1 Introduction 19.2 Data Example 19.3 Data Analysis Using SPSS Statistical Software Version 29 19.4 Cox Regression 19.5 Accelerated Failure Time Model with Weibull Distribution 19.6 Accelerated Failure Time Model with Exponential Distribution 19.7 Accelerated Failure Time Model with Log Normal Distribution 19.8 Accelerated Failure Time Model with Log Logistics Distribution 19.9. Conclusion 19.10 References Chapter 20: Alcohol Relapse after Detox Program with 3 Predictors 20.1 Introduction 20.2 Data Example 20.3 Data Analysis Using SPSS Statistical Software Version 29 20.4 Cox Regression 20.5 Accelerated Failure Time Model with Weibull Distribution 20.6 Accelerated Failure Time Model with Exponential Distribution 20.7 Accelerated Failure Time Model with Log Normal Distribution 20.8 Accelerated Failure Time Model with Log Logistics Distribution 20.9 Conclusion 20.10 References Chapter 21: Ayurvedic Therapy for Human Immunodeficiency Virus 21.1 Introduction 21.2 Data Example 21.3 Data Analysis Using SPSS Statistical Software Version 29 21.4 Cox Regression 21.5 Accelerated Failure Time Model with Weibull Distribution 21.6 Accelerated Failure Time Model with Exponential Distribution 21.7 Accelerated Failure Time Model with Log Normal Distribution 21.8 Accelerated Failure Time Model with Log Logistics Distribution 21.9 Conclusion 21.10 References Chapter 22: Time to Event other Than Cox 22.1 Introduction 22.2 Cox with Time Dependent Predictors 22.3 Segmented Cox 22.4 Interval Censored Regressions 22.5 Autocorrelations 22.6 Polynomial Regressions 22.7 Conclusion 22.8 References Chapter 23: Abstracts of the Chapters 1 to 22 References

Reviews

Author Information

Ton J. Cleophas is internist-clinical pharmacologist at the Department of Medicine Albert Schweitzer Hospital Dordrecht the Netherlands. He is also professor of Statistics and member of the Scientific Committee of the European College of Pharmaceutical Medicine Lyon France. He is particularly interested in machine learning methodologies and published many complete-overview-textbooks of the subject. Aeilko H. Zwinderman is professor of Statistics and Chair of the Department of Biostatistics and Epidemiology at the University of Amsterdam the Netherlands. His current work focuses on development and validation of multivariable models, particularly in genetic research, and he is a major developer of penalized canonical analysis. 

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions